These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9516977)

  • 41. BRCA1 mutations and survival in women with ovarian cancer.
    Brunet JS; Narod SA; Tonin P; Foulkes WD
    N Engl J Med; 1997 Apr; 336(17):1256; author reply 1256-7. PubMed ID: 9121524
    [No Abstract]   [Full Text] [Related]  

  • 42. Familial ovarian cancer.
    Buller RE; Anderson B; Connor JP; Robinson R
    Gynecol Oncol; 1993 Nov; 51(2):160-6. PubMed ID: 7903948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRCA1 mutations and survival in women with ovarian cancer.
    Whitmore SE
    N Engl J Med; 1997 Apr; 336(17):1254-5; author reply 1256-7. PubMed ID: 9121520
    [No Abstract]   [Full Text] [Related]  

  • 44. BRCA1 mutations and survival in women with ovarian cancer.
    Johannsson O; Ranstam J; Borg A; Olsson H
    N Engl J Med; 1997 Apr; 336(17):1255-6; author reply 1256-7. PubMed ID: 9121523
    [No Abstract]   [Full Text] [Related]  

  • 45. BRCA1 mutations and survival in women with ovarian cancer.
    Cannistra SA
    N Engl J Med; 1997 Apr; 336(17):1254; author reply 1256-7. PubMed ID: 9121519
    [No Abstract]   [Full Text] [Related]  

  • 46. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.
    Jóhannsson OT; Ranstam J; Borg A; Olsson H
    J Clin Oncol; 1998 Feb; 16(2):397-404. PubMed ID: 9469321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased incidence of brain metastases in BRCA1-related ovarian cancers.
    Sekine M; Yoshihara K; Komata D; Haino K; Nishino K; Tanaka K
    J Obstet Gynaecol Res; 2013 Jan; 39(1):292-6. PubMed ID: 22889437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation.
    Gorodnova TV; Sokolenko AP; Ivantsov AO; Iyevleva AG; Suspitsin EN; Aleksakhina SN; Yanus GA; Togo AV; Maximov SY; Imyanitov EN
    Cancer Lett; 2015 Dec; 369(2):363-7. PubMed ID: 26342406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical features and disease course in patients with BRCA1-dependent ovarian cancer].
    Blecharz P; Szatkowski W; Bodzek M; Łuczyńska E
    Ginekol Pol; 2012 May; 83(5):353-6. PubMed ID: 22708332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of effectiveness of treatment of patients with sporadic and germline BRCA1-related ovarian cancer.
    Szatkowski W; Muzykiewicz K; Jasiówka M; Karolewski K; Kojs Z; Klimek M; Blecharz P
    Ginekol Pol; 2016; 87(6):422-5. PubMed ID: 27418218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival in epithelial ovarian cancer patients with prior breast cancer.
    McGuire V; Whittemore AS; Norris R; Oakley-Girvan I
    Am J Epidemiol; 2000 Sep; 152(6):528-32. PubMed ID: 10997542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRCA1 mutations and survival in women with ovarian cancer.
    Modan B
    N Engl J Med; 1997 Apr; 336(17):1255; author reply 1256-7. PubMed ID: 9121522
    [No Abstract]   [Full Text] [Related]  

  • 53. BRCA1 mutations and survival in women with ovarian cancer.
    Burk RD
    N Engl J Med; 1997 Apr; 336(17):1255; author reply 1256-7. PubMed ID: 9121521
    [No Abstract]   [Full Text] [Related]  

  • 54. BRCA1, pathology, and survival.
    Lynch HT; Watson P
    J Clin Oncol; 1998 Feb; 16(2):395-6. PubMed ID: 9469320
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinicopathological comparisons of familial and sporadic cases in 219 consecutive Japanese epithelial ovarian cancer patients.
    Sagawa T; Yamashita Y; Fujimoto T; Yamada H; Hoshi N; Sakuragi N; Fujimoto S
    Jpn J Clin Oncol; 1999 Nov; 29(11):556-61. PubMed ID: 10678559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One Case of a BRCA1 Germ Line Mutation Ovarian Carcinoma Patient Based on Abnormal Immunohistochemistry Finding.
    Kim HJ; Park JM; Lee HW; Lee EH; Kim MK
    Korean J Pathol; 2014 Oct; 48(5):379-81. PubMed ID: 25366075
    [No Abstract]   [Full Text] [Related]  

  • 57. THE CANCER GERM THEORY.
    Science; 1925 Aug; 62(1600):x. PubMed ID: 17740879
    [No Abstract]   [Full Text] [Related]  

  • 58. Ovarian cancer: At the starting line.
    Seton-Rogers S
    Nat Rev Cancer; 2013 May; 13(5):296-7. PubMed ID: 23535843
    [No Abstract]   [Full Text] [Related]  

  • 59. Ovarian Disease.
    West J Med Surg; 1845 Jan; 3(1):83. PubMed ID: 38209012
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevalence and oncologic outcomes of
    Seo JH; Jeong SY; Kim MS; Kang JH; Paik ES; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Obstet Gynecol Sci; 2019 Nov; 62(6):411-419. PubMed ID: 31777737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.